Home

PA-19-092 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 22

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Chemsex and HIV: prevalence, medical/psychosocial consequences, and treatment NOT-DA-24-002 NIDA Nov 14, 2022 Jan 8, 2026 R21, R01, R03

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest: NCCIH High Priority Pain Research NOT-AT-22-007 NCCIH Dec 20, 2021 Dec 15, 2022 R01, R21, R15, R34
Notice of Special Interest (NOSI): Advancing Research on SUD through Computational Neuroscience NOT-DA-20-022 NIDA May 5, 2020 Sep 8, 2023 R01, R21
Notice of Special Interest (NOSI): Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults NOT-DA-20-014 NIDA Apr 22, 2020 Sep 8, 2023 R01, R03, R21
Notice of Special Interest (NOSI): Neuroimmune Signaling and Function in Substance Use Disorders NOT-DA-20-046 NIDA Apr 7, 2020 Sep 8, 2023 R01, R21, R15, 333
Notice of Special Interest (NOSI): Competitive Revisions for Firearms Injury and Mortality Prevention Research NOT-OD-20-089 OBSSR NIA NICHD NIMH NCCIH ODP NIMHD ORWH NIAAA Mar 20, 2020 May 16, 2020 R01, R21
Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain NOT-DA-20-039 NIDA Mar 5, 2020 Sep 8, 2023 R01, R03, R21
Notice of Special Interest (NOSI): Harnessing computational tools for sophisticated analyses of Substance Use Disorder-related behaviors NOT-DA-20-017 NIDA Mar 5, 2020 Sep 8, 2023 R01, R03, R21, 333
Notice of Special Interest (NOSI): Mechanistic Investigations of Psychosocial Factors Associated with Substance Use Disorders NOT-DA-20-005 NIDA Mar 3, 2020 Sep 8, 2023 R01, R21
Notice of Special Interest (NOSI): Drug-drug interactions among substances of abuse, medications to treat HIV infection, and pharmacotherapies to treat substance use disorders NOT-DA-20-013 NIDA Feb 6, 2020 May 8, 2022 R01, R03, R21
Notice of Special Interest (NOSI): Preclinical and Clinical Studies of the Interactions of Opioids and Stimulants NOT-DA-20-007 NIDA Jan 6, 2020 Jun 5, 2023 R03, R21, R01
Notice of Special Interest (NOSI): Modeling Social Contagion of Substance Use Epidemics NOT-DA-20-009 NIDA Jan 2, 2020 Jan 8, 2023 R01, R03, R21
Notice of Special Interest: Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes NOT-AT-20-002 NCCIH Dec 13, 2019 Jan 8, 2022 R01, R21
Notice of Special Interest: NIMHs Interest in Early Stage Clinical and/or Mechanistic Trials in Posttraumatic Psychopathology, Directed at Testing FAAH Inhibitors NOT-MH-19-055 NIMH Oct 17, 2019 Jan 8, 2022 U01, R61/R33, R21, R01
Notice of Special Interest in High Priority Research Areas for Sex and Gender Influences on the Adolescent Brain and the Mental Health of Girls and Young Women (Ages 12-24) NOT-MH-19-039 NIMH Sep 9, 2019 May 18, 2022 R21, R01, P50
Notice of Special Interest (NOSI) of NIDCD and NEI in Supporting Research on Usher Syndrome NOT-DC-19-007 NIDCD NEI Sep 4, 2019 Jan 8, 2022 U01, R01, R21, R24, P50, UG1
Notice of Special Interest (NOSI): Public Health Research on Cannabis NOT-DA-19-065 NIDA Aug 14, 2019 Jan 8, 2022 R01, R21, R03, 333
Notice of Special Interest (NOSI): The Application of Big Data Analytics to Drug Abuse Research NOT-DA-19-041 NIDA Jul 12, 2019 Jan 8, 2022 R01, R21, R03
Notice of Special Interest (NOSI): Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R01, R21, R03) NOT-DA-19-037 NIDA Jul 11, 2019 Sep 8, 2022 R01, R21, R03
Notice of Special Interest (NOSI): Research to Prevent Drug Use, Misuse and Addiction NOT-DA-19-048 NIDA Jul 10, 2019 Jan 8, 2022 R01, R21, R03
Notice of Special Interest (NOSI): Gene-Environment Interplay in Substance Use Disorders (R01, R21) NOT-DA-19-038 NIDA Jul 10, 2019 Jan 8, 2022 R01, R21
Notice of Availability of Competitive Supplements/Revisions for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Competitive Supplement/Revision Clinical Trial Optional) NOT-OD-19-071 NIH Feb 5, 2019 Mar 17, 2019 R01, R03, R21, U01


Technical Issues: E-mail OER Webmaster   




  • National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892

  • NIH... Turning Discovery Into Health